General

Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii is an international, peer-reviewed, dermatologic journal. The Journal publishes reports describing original research on all aspects of allergology, cutaneous biology and skin diseases. The Journal is indexed by PubMed, EMBASE, and MNiSW (Ministerstwo Nauki i Szkolnictwa Wyższego – Ministry of Science and Higher Education).

Original Articles and Letters to the Editor are standard features. Review articles should be submitted only after consultation with the Editor-in-Chief. Special articles, Conference reports and Book reviews are invited by the Editorial Board. Case reports, unless they provide new biologic insights, are rarely appropriate for the Journal.

The journal applies procedures ensuring the originality of manuscripts in accordance with the criteria of the ICMJE (International Committee of Medical Journal Editors) and WAME (World Association of Medical Editors). Therefore, it is also necessary to provide information on the scope of input of each author to the publication, among others who is the author of the concept of the study, assumptions, methods, study protocol, and the like, as well as on the affiliation of each of the authors. The editorial office observes the highest standards of scientific publication and the cooperation with authors is based on the transparency of information on the actual input of persons/institutions in the development of the publication. All cases of ghostwriting and guest authorship will be liable for customary penalty as an indication of scientific negligence.

Article types

Original articles

Original articles should not exceed 3,500 words and 6 figures or tables. Original articles should be organized as follows: Title page, Abstract, Introduction, Aims, Material and methods, Results, Discussion, Conflict of interest, Acknowledgments, References, Tables, Figure legends, Supplementary material.

Review articles

A review article is expected to be comprehensive, scholarly, and balanced, presenting an expert curation of the literature on the topic of interest. Reviews are limited to 100-word abstract; 3,000-word text, excluding references; and 2 figures. Authors are encouraged to consult the Editor-in-Chief before submitting a review for consideration.

Letters to the Editor

Letters to the Editor may report original data or discuss published articles. Letters are not to exceed 1,000 words and 2 figures or tables, and 15 references – not to exceed 3 printed journal pages. Letters should not have an abstract. The Editor may solicit a response from the authors if a letter refers to an article published in Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. Letters that report original data will be fully peer-reviewed. All Letters to the Editor are subject to editing and possible abridgment.

Review Process

Articles are selected for publication in double blind selection system and published in open access system. The Editor-in-Chief selects reviewers - usually two or more - based on the submission topic and experts’ academic credentials (based on their academic achievements and review experience). Reviewer shall review by the electronic system on the basis of questions prepared for a specific title. It is also possible for a reviewer to send individual comments to be published in the article content. All judgments and findings in the peer-review process should be objective. Reviewers should have no conflict of interest (they make a statement before proceeding to review.). Reviewers - if is a legitimate need - should point out relevant published work which is not yet cited, and reviewed by them articles should be treated confidentially prior to their publication.

Research and review submissions from the Editor-in-Chief and other journal staff members are processed by the Associate Editors who declare no conflicts of interest in the journal's online submission system. The Editor-in-Chief does not have access to their own submissions and cannot influence the selection of peer reviewers.

Manuscripts published in special and thematic issues undergo the same review and acceptance process as manuscripts published in regular issues. The Editors of a given issue are responsible for carrying out this process.

The manuscript submission

Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii requires electronic submission of manuscripts using the Editorial System.

All Submissions MUST include a cover letter stating:

1. The data in the manuscript are original and the manuscript is not under consideration elsewhere;

2. None of the manuscript contents have been previously published except in abstract form;

3. All authors have read and approved all versions of the manuscript, its content, and its submission to the Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii;

4. The corresponding author's address, telephone, fax, email (email address required).

5. Count of words of paper, numbers of tables and figures.
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii also consider high quality papers under the Fast Track Review scheme. This scheme relies on a dedicated group of top class reviewers to deliver a final decision on reviewed manuscripts within fourteen days and the possibility of online publishing in next 2 weeks after acceptance. The authors need to indicate that they want to have their paper proceed as a fast-track review during the submission process and additionally inform the Editor about this (kontakt@drjankowski.pl). The scheme requires an additional fee to the standard one from authors - from May 15 it will be all together 900 Euro/4320 PLN.

Manuscript preparation

A. General

The manuscript should be double-spaced throughout with 1" wide margins. Number pages consecutively (with the title page as page 1). Begin a new page for reference lists, tables, and figure legends. The file should use the wrap-around end-of-line feature, i.e., returns at the end of paragraphs only. The paper should be concise, economical of references, figures and tables, and formatted as described below. Reports of investigative studies should be organized as follows, within the stated word limits: Title page, Abstract, Introduction, Aims, Material and methods, Results, Discussion, Conflict of interest, Acknowledgments, References, Tables, Figure legends, Supplementary material. Manuscripts that do not conform to these specifications will be returned to the authors for correction prior to review.

B. Word limits

Word limits will be instituted for all manuscripts accepted after January 1, 2024.

• Original articles should not exceed 3,500 words and 6 figures or tables.

• Letters to the Editor should not exceed 1,000 words, 2 figures or tables, and 15 references.

• Word counts include text only; the abstract, references, figure legends, tables, and supplemental data are excluded.

• There may be exceptions, which will be handled at the discretion of the Editor.

• Submissions that do not comply with these guidelines will be returned to authors for revision.

C. Title

The title page should include the following:

• Brief, informative title (brand names may not be used in the title)

• Full names of the author(s), together with academic titles, the address of the academic institution they are members of, and the academic title and full name of the head of that institution

• The name of the department, hospital or laboratory in which the study was conducted, and the name of the department to which the work should be attributed

• Corresponding author's address, telephone, fax and email (email address required)

• 3–6 key words in English.

• Count of words of paper, numbers of tables and figures.

D. Abstract

Abstracts of original papers should be 200–250 words long and consist of 5 distinct parts, i.e. the introduction; aims; materials and methods; results; and conclusions. Abstracts of review papers should be 100–150 words long. Brand names may not be used in the abstract.

E. Material and methods

Readers should be able to reproduce the experiments from the information in the methods section, figure legends, table footnotes, and references. Provide the manufacturer's name and location for materials purchased. This would normally include access to the identity (chemical formula) and doses of all reagents employed.

When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the Helsinki Declaration of 1975, as revised in 2000 (concerning the ethical principles for the medical community and forbidding releasing the name of the patient, initials or the hospital evidence number) and with the ethical standards of the responsible committee on human experimentation (institutional and national). Information regarding the ethical committee approval for conducting the research and the informed consent of patients for participating in the studies should be included in the methods section of those articles, in which the diagnostic intervention or the treatment result from non-routine procedures. The authors presenting case studies are obligated not to disclose patients' personal data. Regarding photographs, in case of any doubt whether the picture inadequately protects the patient's anonymity his consent is required for publication. Articles describing animal studies should contain information of being in accordance with local regulations (institutional and national).

F. Results and Discussion

Results briefly present the experimental data in text, tables or figures (for details, see items J and K below). The Discussion should focus on the interpretation and significance of the findings with concise objective comments that describe their relation to other work in the area. Do not repeat information in Results. Results and Discussion may be presented separately or combined into a single section.

Results should be presented as running text (sentences), tables or figures; only the most important conclusions must be stated. The results of laboratory studies and the relevant standards and standard deviations should be expressed using SI units.

G. Conflict of interest

Conflict of interest. Authors are expected to describe sources of the research funding, a role of the potential sponsor in planning, executing and analysis in the study, and the influence (bias) the funding organization had on the content of the article. Other relationships (such as employment, consultancies, stock ownership, honoraria, paid expert testimony) providing potential sources of conflict of interest in relation to the submitted article should also be revealed.

H. Acknowledgments

A note of acknowledgment is appropriate recognition for contributors who may not be listed as authors.

I. References

References in the order in which they appear in the body text. The references in the body text should be numbered consecutively in the order in which they are cited; the numbers should be given in square brackets ([ ]). The list of references at the end of the article should indicate the authors’ surnames and initials (if there are more than four authors, the names of the first three are to be given, followed by et al.), title of the paper, abbreviated journal title (as per Index Medicus), year of publication, volume number and pages. Book chapters and monographs should be identified using the author’s surname and initial, title of the chapter, title of the book, the surname(s) and initial(s) of the editor(s) of the volume, name of the publisher, place of publication, year, volume and pages.

Example references

Journal article: Oszukowska M, Michalak I, Gutfreund K, et al. Role of primary and secondary prevention in atopic dermatitis. Adv Dermatol Allergol 2015; 32: 409-20.

Book: French MAH. Immunoglobulins in health and disease. MTP Press. Lancaster, UK 1986.

Book chapter: Bron JD. Early events in the infection of the arthropod gut by pathogenic insect viruses. In: Invertebrate Immunity. K Maramorosch, RE Shope (eds). Academic Press. New York, San Francisco, London 1976; 80-111.

Any citations to unpublished works must be shown as footnotes to the text, not in the reference list. Footnotes should be included in parentheses in the text.

J. Tables

Tabular presentations should be self-explanatory and not duplicate content in the text. Tables should be presented at the end of the manuscript (one table per page), numbered sequentially using roman numerals and cited in the chronological order in the text.

K. Figures

Figures should be intelligible without reference to the text and should complement the text. Figures should be labeled sequentially (1, 2, 3) and cited in the text, but not embedded within the text. Figures should be submitted in an electronic format, saved as .cdr, .tif, .jpg or .eps files. Photographs submitted to the journal in an electronic format should have a resolution of at least 300 dpi.

L. Abbreviations

Abbreviations used in the text should be explained at first mention (this also applies to the abstract). Other than in exceptional situations, abbreviations should not be used in the title of the submission.

ETHICAL STANDARDS AND PROCEDURES

Termedia Publishing House is committed to upholding standards of ethical behaviour at all stages of the publication process. We follow closely the industry associations, such as the Committee on Publication Ethics (COPE), International Committee of Medical Journal Editors (ICJME) and World Association of Medical Editors (WAME), that set standards and provide guidelines for best practices in order to meet these requirements.

DUTIES AND RESPONSIBILITIES OF AUTHORS

The Author(s) is obliged to prepare and send the article in accordance with the requirements set out in the journal Editor. Moreover the Author(s) is obliged to submit editorial complemented by a statement which will be included: a statement about the originality of the content of the article (work not yet published anywhere), the integrity of the copyrights of others, no conflict of interest or its application, as well as the superior permission to publish an article in the journal. Authors are obliged to participate in peer review process. The Author(s) are obliged to provide retractions or corrections of mistakes, they also should provide a list of references.

Author(s) are responsible for disclosing all financial and personal relationships that might bias or be seen to bias their work.

Authors may, at any time before accepting the article for publication, withdraw the article by submitting a statement in the electronic system of the Editorial System.

AUTHORSHIP CRITERIA AND/OR WHO SHOULD BE LISTED AS A CONTRIBUTOR

Termedia Publishing House in the matter of authorship criteria and/or who should be listed as a contributor, respects standards recommended by COPE (Committee on Publication Ethics). Detailed information about those criteria you can find in COPE Report publicationethics.org/files/2003pdf12_0.pdf.

DUTIES AND RESPONSIBILITIES OF REVIEWERS

Articles are selected for publication in double blind selection system and published in open access system. Reviewer shall review by the electronic system on the basis of questions prepared for a specific title. It is also possible for a reviewer to send individual comments to be published in the article content.

All judgments and findings in the peer-review process should be objective. Reviewers should have no conflict of interest (they make a statement before proceeding to review.). Reviewers - if is a legitimate need - should point out relevant published work which is not yet cited, and reviewed by them articles should be treated confidentially prior to their publication.

DUTIES AND RESPONSIBILITIES OF EDITORS

Editors are responsible for deciding which articles are accepted for publication. Editors act in a balanced, objective and fair way while carrying out their expected duties, without discrimination on grounds of gender, sexual orientation, religious or political beliefs, ethnic or geographical origin of the authors.

Publisher and Editors are always ready to publish corrections, clarifications, withdrawals and apologies if there is a legitimate need.

In the situation when there is a suspicion that an inappropriate research procedure described in the work sent by autors has taken place, the authors are obliged by the editorial office - if not yet submitted - to submit information regarding the approval of the described research procedure by a properly established ethics committee to conduct clinical trials.

Publication charge

Please note! Since 15 May 2023 there is an obligatory charge (EUR 450/PLN 2160) for each manuscript which is submitted for publication in Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii journal. We send invoices for payment after articles are accepted for publication. Termedia Sp. z o.o. does not pay bank transfer costs.

PayPal (EUR) is the preferred way of payment. However, if this is impossible, payments can be made directly to the following bank accounts:

Payment in EUR:

PL 21 1090 1359 0000 0001 0601 0708

Termedia sp. z o.o.

ul. Kleeberga 8

61-615 Poznań

SANTANDER POLSKA S.A.

- SWIFT: WBKPPLPP

- amount: 450 EUR

- title: Publication fee for ARTICLE-SIGNATURE

Payment in PLN:

PL 61 1090 1359 0000 0000 3505 2645

Termedia sp. z o.o.

ul. Kleeberga 8

61-615 Poznań

SANTANDER POLSKA S.A.

- SWIFT: WBKPPLPP

- amount: 2160 PLN

- title: Publication fee for ARTICLE-SIGNATURE

The fee applies only to the cost of preparing/developing the article for publication in the journal. The fee has no effect on the acceptance of the article for publication. All articles submit by editorial system are reviewed by independent experts outside the editorial office and based on their opinions are qualified or not for publication.
Please be informed that if the author decides not to publish the work, which was already accepted and paid, the fee paid will not be returned for reasons beyond the Publisher’s control.